ScholarIQanswers from OpenAlex & ORCID
Itamar Raz
ResearcherPublications, citations & collaboration network
Itamar Raz is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Itamar Raz have?
ScholarIQindexed works
Itamar Raz has 543 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Itamar Raz have?
ScholarIQcitation count
Itamar Raz has 39,842 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Itamar Raz?
ScholarIQh-index
Itamar Raz has an h-index of 77 in OpenAlex.
What is the i10-index of Itamar Raz?
ScholarIQi10-index
Itamar Raz has an i10-index of 299 in OpenAlex.
What is the ORCID of Itamar Raz?
ScholarIQorcid
The ORCID for Itamar Raz is on the source record.
What is the OpenAlex record for Itamar Raz?
ScholarIQopenalex
The OpenAlex for Itamar Raz is on the source record.
What are the most-cited papers on Itamar Raz?
ScholarIQmost cited works
Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 Diabetes
Edmund J. Lewis, Lawrence G. Hunsicker, William R. Clarke, Tomás Berl, Marc A. Pohl, Julia B. Lewis, Eberhard Ritz, Robert C. Atkins, Richard Rohde, Itamar Raz
Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus
Benjamin M. Scirica, Deepak L. Bhatt, Eugene Braunwald, Philippe Gabríel Steg, Jaime A. Davidson, Boaz Hirshberg, Peter Öhman, Robert Frederich, Stephen D. Wiviott, Elaine Hoffman, Matthew A. Cavender, Jacob A. Udell, Nihar R. Desai, Ofri Mosenzon, Darren K. McGuire, Kausik K. Ray, Lawrence A. Leiter, Itamar Raz
SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
Thomas A. Zelniker, Stephen D. Wiviott, Itamar Raz, KyungAh Im, Erica L. Goodrich, Marc P. Bonaca, Ofri Mosenzon, Eri Kato, Avivit Cahn, Remo H.M. Furtado, Deepak L. Bhatt, Lawrence A. Leiter, Darren K. McGuire, John Wilding, Marc S. Sabatine
Type 2 diabetes mellitus
Ralph A. DeFronzo, Ele Ferrannini, Leif Groop, Robert R. Henry, William H. Herman, Jens J. Holst, Frank B. Hu, C. Ronald Kahn, Itamar Raz, Gerald I. Shulman, Donald C. Simonson, Marcia A. Testa, Ram Weiss
Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)
Authors Task Force Members, L Rydén, Eberhard Standl, M. Bartnik, Greet Van den Berghe, John Betteridge, Menko‐Jan de Boer, Francesco Cosentino, Bengt Jönsson, Markku Laakso, K. Malmberg, Silvia G. Priori, Jan Östergren, J Tuomilehto, Inga S. Þráinsdóttir, Other Contributors, Ilse Vanhorebeek, Marco Stramba‐Badiale, Peter Lindgren, Qing Qiao, Silvia G. Priori, J J Blanc, Andrzej Budaj, A. John Camm, V. Dean, Jaap W. Deckers, Kenneth Dickstein, J. Lekakis, Keith McGregor, Marco Metra, João Morais, A. Osterspey, Juan Tamargo, José Luís Zamorano, Document Reviewers, Jaap W. Deckers, M Bertrand, B Charbonnel, Erland Erdmann, Ele Ferrannini, Allan Flyvbjerg, H. Gohlke, J.R.G. Juanatey, Ian Graham, Pedro Monteiro, Klaus G. Parhofer, Kalevi Pyörälà, Itamar Raz, Guntram Schernthaner, Massimo Volpe, David M. Wood